entertainment -WSS

entertainment

author：comprehensive 2025-08-26 10:54:36 - browse：8

A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024 — Cytokinetics CEO Robert Blum spoke last week at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

Cytokinetics, a drugmaker that is expected to soon launch a promising new heart therapy called aficamten, said Wednesday that it had agreed to pay biotech firm Royalty Pharma a higher royalty on the medicine in return for up to $575 million, which will be used to fund the marketing of the drug and Cytokinetics’ ongoing research and development efforts.

Cytokinetics shares fell nearly 10% in after-hours trading after the announcement, which investors viewed as lowering the odds that the company will be purchased by a larger pharmaceutical company.

The firm also said that it would be raising $500 million through a stock sale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： STAT Readout: Today's biotech news includes Sana and Amylyx

WSS

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Altering the blood type of lungs raises potential for universal organs for transplants

Female surgeons have lower rates of long

Mom launches Girl Scout troop for LGBTQ youth in Texas

Humana CEO Bruce Broussard to step down in 2024

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

leisure time

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

What does generative AI mean for health care? We asked experts

Senate panel passes drug pricing bills, but drops one PBM reform

Alkermes shareholders re

European regulators consider appeal over Amylyx ALS drug

Malaria cases in Florida and Texas: Here’s what you need to know

Timeline: Key moments in fight for gay rights

Activists slam private health insurers over coverage restrictions

Massive project maps cells in human brain in unprecedented detail

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Can medical device makers keep up in the race to treat obesity?

entertainment

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Bispecific antibodies are next new thing in cancer immunotherapy

A revolution in caring for preterm infants

Eli Lilly’s Mounjaro succeeds in second weight

Bispecific antibodies are next new thing in cancer immunotherapy

How should state employee insurance handle Wegovy?

entertainment

hotspot

Wikipedia

leisure time